Hematologic Malignancies [6.2]

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Hematologic Malignancies [6.2]

Writer and Curator:  Larry H. Bernstein, MD, FCAP

Hematologic Malignancies 

Not excluding lymphomas [solid tumors]

The following series of articles are discussions of current identifications, classification, and treatments of leukemias, myelodysplastic syndromes and myelomas.

6.2 Hematological Malignancies

6.2.1 Ontogenesis of blood elements Erythropoiesis White blood cell series: myelopoiesis Thrombocytogenesis

6.2.2 Classification of hematopoietic cancers Primary Classification Acute leukemias Myelodysplastic syndromes Acute myeloid leukemia Acute lymphoblastic leukemia Myeloproliferative Disorders Chronic myeloproliferative disorders Chronic myelogenous leukemia and related disorders Myelofibrosis, including chronic idiopathic Polycythemia, including polycythemia rubra vera Thrombocytosis, including essential thrombocythemia Chronic lymphoid leukemia and other lymphoid leukemias Lymphomas Non-Hodgkin Lymphoma Hodgkin lymphoma Lymphoproliferative disorders associated with immunodeficiency Plasma Cell dyscrasias Mast cell disease and Histiocytic neoplasms

6.2.3 Secondary Classification Nuance – PathologyOutlines

6.2.4 Diagnostics

Ver la entrada original 18.877 palabras más

Entrada siguiente
Deja un comentario


Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )


Conectando a %s

A %d blogueros les gusta esto: